Researchers discovered that the prostate cancer (PCa)-associated LNCaP cell line has a low metastatic rate and therefore expresses higher RKIP levels than the cells of the derivative cell line C4-2B, which contained a high metastatic rate [1,23]. This evidence concerns the gene PEBP1 and Familial prostate cancer.